De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients

Clinical trial NCT06557421 · RECRUITING

Trial details

NCT number: NCT06557421
Sponsor: Institut Paoli-Calmettes
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2026-02-04
Primary completion: 2028-11-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.